Evidence map›Paper›PMID 18287580›Full record

ArticleClinical and vaccine immunology : CVI2008

Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.

Heather MacLeod, Navneet Bhasin, Lee M Wetzler

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Heather MacLeodDepartment of Microbiology, Immunology Training Program, Evans Biomedical Research Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Navneet Bhasin
Lee M Wetzler
Boston University · US

Funding

Neisserial Porins and Antigen Presenting CellsR01AI040944 · NIAID · BOSTON MEDICAL CENTER · PI WETZLER, LEE MARK · 1997 to 2019
$9.3M
Effect of Neisserial Porin in Immune Cell ApoptosisR01AI049388 · NIAID · BOSTON MEDICAL CENTER · PI WETZLER, LEE MARK · 2002 to 2006
$1.7M
Neisserial porins and antigen presenting cellsR56AI040944 · NIAID · BOSTON MEDICAL CENTER · PI WETZLER, LEE MARK · 2015 to 2015
$429k
NIAID NIH HHS AI040944NIAID NIH HHS AI049388NIAID NIH HHS R01 AI040944NIAID NIH HHS R01 AI049388NIAID NIH HHS R56 AI040944
6 · The paper itself

Abstract

Neisserial porins are potent immune adjuvants and have been demonstrated to stimulate and induce the activation of human and murine B lymphocytes. Their immunopotentiating ability is due largely to the upregulation of the surface expression of the costimulatory ligand CD86 (B7-2) on B cells and other antigen-presenting cells. Porin-induced activation is dependent on the innate immune pattern recognition receptor Toll-like receptor 2 (TLR2). These data have led us to investigate the signal transduction events induced by PorB from Neisseria meningitidis and then, using inhibitors of these pathways, to establish the mechanism by which this bacterial major outer membrane protein induces CD86 upregulation and the proliferation of murine B cells. PorB was able to induce (i) protein tyrosine kinase (PTK) activity, (ii) the phosphorylation of Erk1 and Erk2, and (iii) IkappaB-alpha phosphorylation, leading to NF-kappaB nuclear translocation in B cells in a TLR2-dependent manner. PorB-induced NF-kappaB nuclear translocation was not dependent on either PTK or Erk1/2 activities. However, B-cell proliferation and the induction of increased surface expression of CD86 by PorB were dependent on PTK activity and not Erk1/2 activation. In conclusion, PorB acts through TLR2 as a B-cell mitogen, triggering tyrosine phosphorylation of various cellular proteins that are involved in proliferation and CD86 expression, as well as the phosphorylation of Erk1/2, which is not necessary for CD86 upregulation or the proliferation of B cells.

Indexed as

Active Transport, Cell NucleusAnimalsB7-2 AntigenB-LymphocytesLymphocyte ActivationMiceMice, Inbred C3HMice, Inbred C57BLMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Neisseria meningitidisNF-kappa BPhosphorylationPorinsProtein-Tyrosine KinasesSignal TransductionB7-2 AntigenCd86 protein, mouseMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NF-kappa Bporin protein, NeisseriaPorinsProtein-Tyrosine KinasesToll-Like Receptor 2

Identifiers

PMID18287580
PMCPMC2292646
OpenAlexW2171996531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.